Understanding Soluble (pro)renin Receptor in Kidney Scarring

Soluble (pro)renin receptor regulation of kidney fibrosis

NIH-funded research Utah State Higher Education System--University of Utah · NIH-11136313

This research explores how a specific protein called soluble (pro)renin receptor (sPRR) contributes to kidney damage and scarring in people with chronic kidney disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah NIH-funded
Lab location1 site (Salt Lake City, United States)
Project IDNIH-11136313 on NIH RePORTER

What this research studies

Chronic kidney disease (CKD) can lead to irreversible damage and loss of kidney function due to inflammation and scarring. We know that a protein called the (pro)renin receptor (PRR) plays a role in CKD, and a smaller, soluble piece of it, sPRR, is found at higher levels in patients with more advanced CKD. Our team has created a special mouse model that lacks sPRR, and these mice show less kidney injury and scarring. We aim to understand exactly how sPRR contributes to kidney disease progression and identify the cellular processes involved.

Who could benefit from this research

Good fit: This foundational research focuses on understanding disease mechanisms and does not directly involve patient participation at this stage, but future clinical applications would target adults with chronic kidney disease.

Not a fit: Patients without chronic kidney disease or those with kidney conditions not related to the (pro)renin receptor pathway may not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this work could lead to new ways to prevent or slow down kidney scarring and improve outcomes for patients with chronic kidney disease.

How similar studies have performed: While the full-length PRR has been studied, the specific role of soluble PRR in kidney disease is largely unknown, making this a novel area of investigation.

Where this research is happening

Salt Lake City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.